evonetix
Andrew Diston currently serves as the Chief Executive Officer of Evonetix Ltd, a position held since March 2024. Diston has an extensive background in the technology and medical fields, holding various leadership roles including Chairman and Non-executive Director at Byosen Limited and Chief Science and Technology Officer at Science Group plc from September 2016 to October 2019. Previous experience also includes positions such as Executive Vice President at Medicom Innovation Partner, Head of Global Medical Technology Practice at Cambridge Consultants, and Analog Design Engineer roles at Data Conversion Systems and Cambridge Consultants Ltd. Diston began a career in development at Sinclair Research, focusing on consumer electronics. Diston earned an MA in Electrical Sciences from the University of Cambridge between 1981 and 1984.
This person is not in any teams
This person is not in any offices
evonetix
1 followers
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.